Pathology at ACT 2026

Nov 15–18, 2026 San Antonio, TX ~1.4k attendees Website

22 organizations at ACT 2026 present work in pathology: 18 service, testing and tools companies, 3 drug developers and 1 university, agency or non-profit. Between them they bring 59 presentations to the program. Most represented: Labcorp (12 on the program), Charles River (5 on the program), Altasciences (5 on the program). 18 of them have their own page in this guide. As of Oct 8, 2026.

All 231 organizations at ACT 2026 →

Showing 1–5 of 22 organizations

Organization	ACT 2026 Attendance
Labcorp Burlington, NC
labcorp.com Contract research organizations (CROs) Laboratory services company whose drug development arm runs nonclinical toxicology, pathology and safety studies for drug and chemical developers.	Booth Exhibiting at Booth 310 Mon, Nov 169:30am–6:30pmTue, Nov 178:00am–4:30pm Session Sun Nov 15 1:00pm–4:30pm Beyond Animal Models: Navigating New Approach Methodologies in Modern Drug Development with Case Study Examples (CE5) New approach methods · with U.S. Food and Drug Administration 1:00pmIntroduction (CE5-1)U.S. Food and Drug Administration 1:05pmFDA's 2025 Roadmap to Reduce Animal Testing: Leveraging NAMs to Address Preclinical Safety (CE5-2)U.S. Food and Drug Administration 1:30pmNew Approach Methodologies (NAMs): Role of Nonclinical Scientists (CE5-3)Gilead Sciences 2:00pmComplex Human-Derived Models as New Approach Methodologies (NAMs) for Drug Discovery and Development (CE5-4)Sanofi 3:00pmNew Approach Methodologies in Practice: Creating Virtual Control Groups for Nonclinical Studies (CE5-5)Labcorp 3:30pmNAMs Adoption in a Global Drug Development Laboratory (CE5-6)Labcorp Talk Sun Nov 15 3:00pm–3:30pm Part of Beyond Animal Models: Navigating New Approach Methodologies in Modern Drug Development with Case Study Examples (CE5) New Approach Methodologies in Practice: Creating Virtual Control Groups for Nonclinical Studies (CE5-5) Study data · New approach methods Talk Sun Nov 15 3:30pm–4:00pm Part of Beyond Animal Models: Navigating New Approach Methodologies in Modern Drug Development with Case Study Examples (CE5) NAMs Adoption in a Global Drug Development Laboratory (CE5-6) New approach methods Session Mon Nov 16 9:00am–12:00pm Beyond the Vessel Wall: Translational Insights into Vascular Inflammation (S03) Pathology · Translational safety · with Korsana Biosciences 9:00amIntroduction to Vascular Inflammation (S03-1)Korsana Biosciences 9:15amDrug Induced Vascular Injury (DIVI) Related to Biologic Therapies: Mechanisms and Sensitivity (S03-2)International Academy of Toxicologic Pathology 9:45amA Regulatory Perspective (S03-3)ToxStrategies 10:45amBiomarkers of Vascular Injury (S03-4)Merck 11:15amInnovative Tools and Future Directions (S03-5)Kymera Therapeutics Poster Mon Nov 16 5:00pm–6:30pm Applying a Virtual Control Group Retrospectively to a 26-Week Subcutaneous Repeat Dose Toxicity Study in the Cynomolgus Monkey (P508) Nelson Exhibit Ballroom · Poster P508 Study data Poster Mon Nov 16 5:00pm–6:30pm Assessment of a Functional Observational Battery in Minipigs across Multiple Research Sites (P117) Nelson Exhibit Ballroom · Poster P117 Safety pharmacology · Animal models Poster Mon Nov 16 5:00pm–6:30pm Development of an Integration Site Analysis Assay in AAV2 and AAV9 Administered Murine Models (P301) Nelson Exhibit Ballroom · Poster P301 Biologics and new modalities · Genetic toxicology Poster Mon Nov 16 5:00pm–6:30pm Enabling Flexible yet Comparable Cell Counting Strategies in Cell and Gene Product Development: A Comparative Evaluation of Automated Platforms (P206) Nelson Exhibit Ballroom · Poster P206 Biologics and new modalities · Bioanalysis and biomarkers Poster Mon Nov 16 5:00pm–6:30pm Evaluation of Wild Type and Humanized IgG1/4 Göttingen Minipigs for Subchronic Toxicology Assessment of Biotherapeutics (P127) Nelson Exhibit Ballroom · Poster P127 Animal models · Biologics and new modalities Poster Mon Nov 16 5:00pm–6:30pm Feasibility of a Paddling Pool Test (PPT) as an Alternative Assessment to the Morris Water Maze (MWM) in Mice (P517) Nelson Exhibit Ballroom · Poster P517 Neurotoxicology Poster Mon Nov 16 5:00pm–6:30pm MRI-Guided Targeted Delivery of AAV9 to the Putamen of Nonhuman Primates and Göttingen Minipigs: A Translational Framework for CNS Gene and Cell Therapies (P302) Nelson Exhibit Ballroom · Poster P302 Biologics and new modalities · Neurotoxicology Poster Mon Nov 16 5:00pm–6:30pm Nonhuman Primate Species Considerations for Preclinical Gene Therapy Studies (P132) Nelson Exhibit Ballroom · Poster P132 Animal models · Biologics and new modalities Poster Mon Nov 16 5:00pm–6:30pm Pulmonary Embolism of Marrow Tissue Secondary to Bone Marrow Aspiration for Immunophenotyping in Cynomolgus Monkeys (P136) Nelson Exhibit Ballroom · Poster P136 Pathology · Animal models Poster Mon Nov 16 5:00pm–6:30pm Validation of the Cincinnati Water Maze for Egocentric Learning and Memory in Developmental Neurotoxicity Studies (P530) Nelson Exhibit Ballroom · Poster P530 Neurotoxicology · DART Talk Tue Nov 17 8:00am–8:55am Beyond the Roadmaps: Applying Human-Relevant NAMs to Weight-of-Evidence Assessments Grand Oaks Ballroom Q New approach methods · Regulatory
Charles River Wilmington, MA	◆Diamond Supporter
criver.com Contract research organizations (CROs)Diamond Supporter Contract research organization running discovery and GLP safety studies worldwide, including general, genetic, reproductive and neurotoxicology, with study-data and virtual control tools.	Booth Exhibiting at Booth 303 Mon, Nov 169:30am–6:30pmTue, Nov 178:00am–4:30pm Talk Sun Nov 15 8:05am–8:30am Part of Working with Global Regulators for Streamlined Nonclinical Development (CE4) Top Tips for Successful Nonclinical Regulatory Interaction (CE4-2) Regulatory Poster Mon Nov 16 5:00pm–6:30pm Can Jacketed Telemetry Provide QTc Data Which Is Sensetive and Reproducible to Meet ICH E14/S7B Requirements (P510) Nelson Exhibit Ballroom · Poster P510 Safety pharmacology Poster Mon Nov 16 5:00pm–6:30pm Data Driven Strategy Supporting Adequate Virtual Control Groups in Nonclinical Studies (P123) Nelson Exhibit Ballroom · Poster P123 Study data Poster Mon Nov 16 5:00pm–6:30pm Refining General Toxicology with Longitudinal MRI Assessments and AI-Enabled Analytics as a Platform for Cardioxicity and Neurotoxicity Monitoring in Cynomolgus Monkeys and Beagle Dogs (P436) Nelson Exhibit Ballroom · Poster P436 Animal models · Safety pharmacology Talk Tue Nov 17 8:00am–8:55am Virtual Control Groups and Digital Pathology: Shaping the Next Generation of Toxicologic Assessment Grand Oaks Ballroom P Study data · Pathology Talk Tue Nov 17 9:05am–9:30am Part of What Did You Forget on Your Way to Your NDA/MAA? Strategic Considerations for Late-Stage Nonclinical Safety Studies (S09) Immunotoxicity Studies: Integrating Immunotoxicity Assessment into Nonclinical Safety Programs (S09-2) Immunotoxicology Talk Tue Nov 17 12:00pm–12:55pm New Frontiers in NAMs Applications: Cutting-Edge Solutions for Immunogenicity, Developmental and Reproductive Toxicology, and Cardiac Safety Screening Grand Oaks Ballroom R New approach methods Session Wed Nov 18 9:00am–12:00pm Modernizing Drug Development: Advanced Translational Methodologies for CNS and PNS Risk Assessment (S13) Neurotoxicology · with Lilly 9:00amIntroduction on CNS Risk Assessment (S13-1)Lilly 9:10amNeurotoxicology in General Toxicology Studies: Interactive Case Studies to Explore Common Challenges, Regulatory Strategies, and Innovative Approaches (S13-2)Charles River 9:40amMechanistic Insights into Species-Specific Seizure Susceptibility (S13-3)ApconiX 10:45amThe Complexity of Drug Development Illustrated with Nav1.7-Associated Dysautonomia (S13-4)Genentech 11:10amCNS NAMs for modeling of neural plasticity and learning in neural organoids (S13-5)Johns Hopkins University Talk Wed Nov 18 9:10am–9:40am Part of Modernizing Drug Development: Advanced Translational Methodologies for CNS and PNS Risk Assessment (S13) Neurotoxicology in General Toxicology Studies: Interactive Case Studies to Explore Common Challenges, Regulatory Strategies, and Innovative Approaches (S13-2) Neurotoxicology
Altasciences Laval, QC, Canada	◆Diamond Supporter
altasciences.com Contract research organizations (CROs)Diamond Supporter Drug development organization combining nonclinical studies, bioanalysis, early clinical trials, formulation and manufacturing for early-phase programs.	Booth Exhibiting at Booth 304 Mon, Nov 169:30am–6:30pmTue, Nov 178:00am–4:30pm Talk Sun Nov 15 12:00pm–12:55pm Genetic and Biomarker Consistency in Southeast Asian Cynomolgus Monkeys for Preclinical Research Grand Oaks Ballroom N Animal models Poster Mon Nov 16 5:00pm–6:30pm Addressing the Data Gap: Sampling Feasibility and Effects on Clinical Pathology Results after Liver Biopsy in Nonhuman Primates (P115) Nelson Exhibit Ballroom · Poster P115 Pathology · Animal models Poster Mon Nov 16 5:00pm–6:30pm An Internal Study in Sinclair Nanopig® Miniature Swine to Generate Background Data and Reference Ranges (P116) Nelson Exhibit Ballroom · Poster P116 Animal models · Study data Poster Mon Nov 16 5:00pm–6:30pm Pharmacokinetic Studies of Long-Acting Transdermal Buprenorphine in Miniature Swine and Canine (P430) Nelson Exhibit Ballroom · Poster P430 Bioanalysis and biomarkers · Animal models Poster Mon Nov 16 5:00pm–6:30pm Species Divergence in Toxicity Profiling of Lipid Nanoparticle-Oligonucleotide Therapeutics: An Adverse Outcome Pathway-Based Comparison in Rodent and Nonhuman Primate (P439) Nelson Exhibit Ballroom · Poster P439 Biologics and new modalities · Animal models Talk Tue Nov 17 11:15am–11:45am Part of Overcoming the Blood-Brain Barrier and Translational Challenges in the Nonclinical Development of CNS Drugs (S08) Toxicology Challenges and Opportunities for Gene Therapy: CNS-Related Assessment in Animal Models (S08-6) Biologics and new modalities · Neurotoxicology
Boehringer Ingelheim Ingelheim, Germany
boehringer-ingelheim.com Pharmaceutical companies Family-owned German pharmaceutical company developing human medicines and animal health products.	Session Sun Nov 15 8:00am–11:30am First-in-Human Dose Selection: Translational Strategies and Special Considerations across Modalities and Organ Systems (CE1) Translational safety · with Novartis 8:00amFoundational Approaches to FIH Dose Selection (CE1-1)White Oak Regulatory Tox 8:20amModel-Informed Approaches to FIH Dose Prediction (CE1-2)Bedard ADME-Tox Solutions, Tango Therapeutics 8:45amCNS-Delivered Therapeutics: Anatomic, Physiologic, and Modality-Specific Considerations (CE1-3)Akkeri 9:10amInter-Species Dose Extrapolation for Ocular Therapeutics: Translational Frameworks for Eye-Delivered Products (CE1-4)Novartis 10:00amCrossing the Species Divide in Inhaled Dosing (CE1-5)Novartis 10:25amInteractive Session: Hypothetical Challenge Scenarios in FIH Setting (CE1-6)Boehringer Ingelheim Session Sun Nov 15 8:00am–11:30am From Predictive Models to Collaborative Intelligence: The Role of Agentic AI in the Future of Toxicology (CE2) In silico and AI · with Human Chemical 8:00amWelcome and Course Overview (CE2-1)Human Chemical 8:05amAgentic AI 101: A Primer for Drug Discovery and Development Toxicologists (CE2-2)Taiho Oncology 8:30amAgentic AI Frameworks for Predictive Toxicology-Based Literature Searches (CE2-3)Coincidence Labs 9:00amSynthesizing Experimental Results and In-Silico Predictions for Autonomous Hypothesis Generation (CE2-4)Human Chemical 10:00amLeveraging Agentic AI to Reassess and Optimize Previously Failed Compounds (CE2-5)Ignota Labs 10:30amChemistry Foundation Models for Optimal Drug Design (CE2-6)deepmirror Talk Sun Nov 15 10:25am–11:30am Part of First-in-Human Dose Selection: Translational Strategies and Special Considerations across Modalities and Organ Systems (CE1) Interactive Session: Hypothetical Challenge Scenarios in FIH Setting (CE1-6) Translational safety Poster Mon Nov 16 5:00pm–6:30pm IL-10–Associated Thrombocytopenia Is Not Mediated by Direct Platelet Effects (P129) Nelson Exhibit Ballroom · Poster P129 Immunotoxicology · Pathology Poster Mon Nov 16 5:00pm–6:30pm Strengthening Regulatory Confidence in Liver MPS: Insights from The 3Rs Collaborative’s & FDA CDER’s Cross Platform DILI Project (P213) Nelson Exhibit Ballroom · Poster P213 New approach methods · Regulatory Session Tue Nov 17 9:00am–12:00pm Next-Generation Liver Toxicity Assessment: Integrating Human-Relevant NAMs, AI, and Exposure Modeling (S07) New approach methods · In silico and AI · with Physicians Committee for Responsible Medicine 9:00amIntroduction (S07-1)Physicians Committee for Responsible Medicine 9:05amAn Integrated NAM Platform Combining Bioactivity Prediction with PBPK and Literature Intelligence for Chemical Liver Toxicity Assessment (S07-2)Human Chemical 9:30amMulticellular Hepatic In Vitro Models Using NANOSTACKS™: Flow-Driven Differential Toxicity and Human-Relevant Drug Response Prediction (S07-3)Revivocell 9:55amAI-Enabled, Exposure-Anchored DILI Prediction Using Human 3D Liver Microtissues (S07-4)InSphero 10:45amFrom Exposure Dynamics to Uncertainty: A Hybrid Framework for Drug-Induced Liver Injury Prediction (S07-5)ESQlabs 11:25amNovel Optical Techniques to Study Hepatic Microplastic Pollution: Optical Imaging as a Powerful New Approach Methodology (S07-6)University of New Mexico Talk Wed Nov 18 2:00pm–2:20pm Part of The Versatile Toxicologist: How to Leverage Expertise into Opportunity (S16) Conventional and Unconventional Trajectories to a Toxicologist Career in the Pharmaceutical Sector (S16-1) Careers
Virscio New Haven, CT
virscio.com Contract research organizations (CROs) Translational contract research organization running nonhuman primate safety, efficacy and disease-model studies, plus standalone histopathology for all species.	Booth Exhibiting at Booth 713 Mon, Nov 169:30am–6:30pmTue, Nov 178:00am–4:30pm Poster Mon Nov 16 5:00pm–6:30pm Comparative Study Designs for Vaccine Evaluation in African Green Monkeys (AGM) (P407) Nelson Exhibit Ballroom · Poster P407 Animal models Poster Mon Nov 16 5:00pm–6:30pm Comprehensive Ophthalmic Normative Data for the African Green Monkey (Chlorocebus Sabaeus): A Translational Reference for Ocular Drug Safety and Efficacy (P410) Nelson Exhibit Ballroom · Poster P410 Animal models · Study data Poster Mon Nov 16 5:00pm–6:30pm Seeing Precision: X-Ray Visualization of Direct Trigeminal Ganglion Administration in African Green Monkeys (P526) Nelson Exhibit Ballroom · Poster P526 Animal models · Neurotoxicology Poster Mon Nov 16 5:00pm–6:30pm Untangling Obstacles to Increase Tissue Biodistribution for Nonsystemic Administration of Antisense Oligonucleotides to Neonatal, Juvenile, and Mature African Green Monkeys (P446) Nelson Exhibit Ballroom · Poster P446 Biologics and new modalities · DART

Instantly find 20 buyers in pathology

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the American College of Toxicology (ACT). Organization details are derived from ACT’s published program, exhibitor floor plan and supporter list, and each organization’s own website. Submit a correction

Instantly find 20 buyers in pathology

Browse ACT 2026 by